Cigna Corp CI
We take great care to ensure that the data presented and summarized in this overview for Cigna Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CI
View all-
Vanguard Group Inc Valley Forge, PA26.8MShares$9.08 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY24.3MShares$8.24 Billion0.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD14.3MShares$4.86 Billion0.64% of portfolio
-
State Street Corp Boston, MA13.3MShares$4.51 Billion0.22% of portfolio
-
Dodge & Cox San Francisco, CA13.1MShares$4.45 Billion2.92% of portfolio
-
Massachusetts Financial Services CO Boston, MA11.1MShares$3.77 Billion1.26% of portfolio
-
Sanders Capital, LLC West Palm Beach, FL7.79MShares$2.64 Billion4.72% of portfolio
-
Morgan Stanley New York, NY6.17MShares$2.09 Billion0.18% of portfolio
-
Geode Capital Management, LLC Boston, MA5.84MShares$1.98 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY4.65MShares$1.57 Billion0.15% of portfolio
Latest Institutional Activity in CI
Top Purchases
Top Sells
About CI
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Insider Transactions at CI
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 15
2024
|
Noelle K Eder Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
875
+4.98%
|
$149,625
$171.38 P/Share
|
May 14
2024
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
SELL
Open market or private sale
|
Direct |
5,946
-69.63%
|
$2,069,208
$348.71 P/Share
|
May 14
2024
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,946
+41.05%
|
$713,520
$120.89 P/Share
|
May 14
2024
|
Noelle K Eder Officer |
SELL
Open market or private sale
|
Direct |
10,700
-40.34%
|
$3,723,600
$348.47 P/Share
|
May 14
2024
|
Noelle K Eder Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,533
+17.26%
|
$946,143
$171.38 P/Share
|
Apr 24
2024
|
William J De Laney Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+2.98%
|
-
|
Apr 24
2024
|
Eric J Foss Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+1.51%
|
-
|
Apr 24
2024
|
Elder Granger Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+8.97%
|
-
|
Apr 24
2024
|
Neesha Hathi Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+16.48%
|
-
|
Apr 24
2024
|
Kathleen M Mazzarella Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+8.97%
|
-
|
Apr 24
2024
|
Kimberly A. Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+12.21%
|
-
|
Apr 24
2024
|
Donna F Zarcone Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+2.02%
|
-
|
Apr 24
2024
|
George Kurian Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+14.65%
|
-
|
Apr 24
2024
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+8.97%
|
-
|
Apr 24
2024
|
Eric C Wiseman Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+2.34%
|
-
|
Apr 24
2024
|
Phillip Ozuah Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+31.67%
|
-
|
Mar 26
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,761
+2.13%
|
$1,078,779
$139.22 P/Share
|
Mar 25
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
31,209
-8.23%
|
$11,079,195
$355.17 P/Share
|
Mar 25
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,209
+7.6%
|
$4,338,051
$139.22 P/Share
|
Mar 22
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,338
-1.79%
|
$2,249,990
$355.11 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 118K shares |
---|---|
Exercise of conversion of derivative security | 198K shares |
Bona fide gift | 63.6K shares |
Payment of exercise price or tax liability | 52.4K shares |
---|---|
Open market or private sale | 221K shares |
Bona fide gift | 67.2K shares |
Discretionary transaction | 503 shares |